Introduction.
Recent developments in our understanding of neuro-endocrine and hormonal factors involved in growth, together with rapid advances in biotechnology, have produced an environment for potentially exciting changes in our ability to regulate animal performance. For example, recombinant DNA technology has made possible the large scale production of metabolic hormones that were previously available only in small quantities. Such use of biotechnology is, however, just one of the steps that need to be taken if the somatotrophic hormones are to be used as a means of improving animal performance. One of the first requirements is to show that the hormones can actually have a beneficial effect ; for the most part, such data are not still available.
The principal somatotrophic hormones are : somatotropin (growth hormone, GH), somatomedin-C (insulin-like growth factor 1, )GF-I somatocrinin (GH releasing factor, GRF) and somatostatin (GH release inhibiting factor, SRIF1. The major potential applications for the somatotrophic hormones are in growth and lactation, however the hormonal control of these phenomena relies upon a com-( 1 ) Present address : c/o Institute of Food Research, Langford, Bristol, Great Britain. plex interaction between many different hormones (Spencer, 1985 (Jagannadha and Ramachandran, 1977) .
It is well known that administration of exogenous growth hormone during established lactation increases milk yield. Consistent positive effects, with increases of between 10 and 40 % in milk yield, have been observed with GH administration to cows during mid-or late-lactation, but the effect on milk production in early lactation is equivocal (Bines and Hart, 1982 ; Brumby and Hancok, 1955 (Mepham et al., 1984) and pigs (Harkins et al., 1985 ).
The precise mechanisms by which GH stimulates milk production are unknown. The catabolic effects of GH are likely to be important in providing at least part of the energy required and it appears that the improvement in milk yield is due to increased utilization of body tissues for milk.production . It also seems possible, however, that increased IGF-1 production following GH treatment in lactation (Peel et al., 1985) may have effects on the mammary gland (Baumrucker, 1986) .
There is neither an apparent increase in digestibility Tyrrell et al., 1982) nor a change in partial efficiency of milk synthesis when lactating cattle are treated with GH, but the increase in milk yield is associated with a marked increase in voluntary food intake within a few weeks of the start of treatment . Depending upon the feeding regime and production response, it has been estimated that this increase in intake may result in up to a 110 % increase in concentrate requirements (Kalter et al., 1985) , however it may still remain a viable approach to increasing overall milk production efficiency.
Perhaps (Ferland et al., 1976) and might be expected to increase milk yields. There is only one published report on the effects of immuno-neutralization of SRIF on milk yield. In a preliminary study with goats it was found that immuno-neutralization of somatostatin during pregnancy resulted in increased milk production up until the time of peak lactation, thereafter there was no difference between treated and control animals (Spencer, Garssen and Welling, 1985) . This preliminary observations needs to be confirmed, but such immuno-neutralization, or use of an antagonist to SRIF (Spencer and Hallett, 1985) could provide an alternative approach to the use of GH.
Growth

Growth hormone
The relative roles of various hormones in regulating growth have recently been reviewed (Spencer, 1985) . Although GH is a central factor in regulating growth, there is little correlation between circulating GH levels and growth rate in normal animals. The reason for this seems to be due to the complex interactions between GH and other hormones that is required for growth (Spencer, 1985) . Thus, although GH is essential for growth, and restores growth in hypopituitary or hypophysectomized animals, its effects on stimulating growth rates in normal farm animal species is far from consistent ; even consecutive studies from the same laboratory produce conflicting results (Wolfram, Ivy and Baldwin, 1985) . Some of the problems associated with this variability in response (e. g. use of heterologous GH, purity, dose) have recently been discussed by Chung, Etherton and Wiggins (1985) .
Some of the studies attempting to stimulate growth using GH are shown in Table 1 . Machlin (1972) (Wehrenberg, Bloch and Phillips, 1984) , but in chickens (Baile, Della-Fera and Buonomo, 1985 ; Leung et al., 1986) and in swine Brande, 1979) animals, but published data on the effects in normal animals are lacking ; unpublished data, however, suggest that exogenous IGF-1 has no effect on total body growth. As with GH and GRF, there is no suitable vehicle available for long-term administration, thus whatever the effects of IGF-1 on growth in farm animal species, its use is at present restricted.
Somatostatin
As an alternative to increasing the levels of growth stimulating hormones it may prove equally, or even more, effective to remove endogenous growth inhibitors. Perhaps the major inhibitor of total somatic growth is SRIF. As well as inhibiting the release of GH, it also inhibits the release of insulin, thyroid hormones and many gastro-intestinal hormones, thereby affecting both the ability of the animal to absorb nutrients and its subsequent ability to direct these nutrients into tissue growth.
The use of a somatostatin antagonist has been found to stimulate growth in rats (Spencer and Hallett, 1985) , but this kind of treatment also suffers from the drawbacks of GH, IGF-1 and GRF in that it requires daily injections. A possible practical alternative is the use of immuno-neutralization. To date, passive immunization of SRIF (administration of antibodies into the animal) has not been found to have any growth stimulating effect , but active immunization appears to be a powerful, safe, effective tool to enhance growth (for a review see Spencer, 1986 (Spencer, Hallett, and Fadlalla, 1985 ; Laarveld et al., 1986) , cattle (Closset et al., 1986 ; Lawrence et aL, 1986) , pigs (Spencer, 1984 ; Laarveld, personal communication) and chickens .
As well as stimulating growth rate and leading to a 20 % reduction in rearing time (Spencer, 1984) , active immunization against SRIF also has a beneficial effect on food conversion efficiency. In addition to the saving on food by virtue of more rapid growth, the animals actually utilise their food more efficiently during the growing period (Spencer, Garssen and Bergstr6m, 1983) , at least partly as a result of changes in gut motility (Fadlalla, Spencer and Lister, 1985 ; Faichney and Barry, 1985 
